We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.02B
AUM Growth
+$247M
Cap. Flow
-$496M
Cap. Flow %
-48.88%
Top 10 Hldgs %
63.97%
Holding
140
New
46
Increased
31
Reduced
3
Closed
42
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$12M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$5.48M
3
OTIC
Otonomy, Inc.
OTIC
+$3.27M
4
INSM icon
Insmed
INSM
+$2.74M
5
FNSR
Finisar Corp
FNSR
+$2.04M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$14.9M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$1.64M
3
RAI
Reynolds American Inc
RAI
+$1.15M
4
AWH icon
Allied World Assurance Co Hld Lt
AWH
+$825K
5
MBLY icon
Mobileye N.V.
MBLY
+$691K

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.88%
2 Healthcare 3.4%
3 Communication Services 0.4%
4 Technology 0.31%
5 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
DBVT icon
26
CALL
DBV Technologies S.A. American Depositary Shares
DBVT
$573M
$2.27M 0.22%
5,340
-17,690
-77% -$7.58M
2017 Q1
2 quarters
NXH icon
27
Neighborhood Intelligence Inc
NXH
$188M
$2.01M 0.2%
+90,069
New +$1.36M
2017 Q3
0 quarters
FNSR
28
DELISTED
Finisar Corp
FNSR
$1.85M 0.18%
+83,400
New +$2.04M
2017 Q3
0 quarters
LPCN icon
29
PUT
Lipocine
LPCN
$13.9M
$1.62M 0.16%
24,118
+13,365
+124% +$966K
2017 Q1
2 quarters
LPCN icon
30
Lipocine
LPCN
$13.9M
$1.59M 0.16%
23,606
+12,912
+121% +$934K
2017 Q2
1 quarter
TEVA icon
31
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$1.48M 0.15%
+83,900
New +$1.89M
2017 Q3
0 quarters
ARAV
32
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$1.37M 0.14%
94,550
+65,567
+226% +$6.61M
2017 Q1
2 quarters
NBR icon
33
Nabors Industries
NBR
$1.16B
$1.28M 0.13%
+3,178
New +$1.16M
2017 Q3
0 quarters
TWX
34
DELISTED
Time Warner Inc
TWX
$1.02M 0.1%
10,000
+5,320
+114% +$540K
2016 Q4
3 quarters
LVLT
35
DELISTED
Level 3 Communications Inc
LVLT
$1.01M 0.1%
19,000
+1,400
+8% +$78K
2016 Q4
3 quarters
STRP
36
DELISTED
Straight Path Communications Inc.
STRP
$813K 0.08%
+4,500
New +$808K
2017 Q3
0 quarters
NBR icon
37
PUT
Nabors Industries
NBR
$1.16B
$807K 0.08%
+2,000
New +$732K
2017 Q3
0 quarters
BCR
38
DELISTED
CR Bard Inc.
BCR
$801K 0.08%
2,500
+834
+50% +$267K
2017 Q2
1 quarter
OTIC
39
DELISTED
Otonomy, Inc.
OTIC
$788K 0.08%
+242,600
New +$3.27M
2017 Q3
0 quarters
SNI
40
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$773K 0.08%
+9,000
New +$741K
2017 Q3
0 quarters
NBR icon
41
CALL
Nabors Industries
NBR
$1.16B
$752K 0.07%
+1,866
New +$683K
2017 Q3
0 quarters
NDRM
42
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$739K 0.07%
+19,000
New +$699K
2017 Q3
0 quarters
PRXL
43
DELISTED
Parexel International Corp
PRXL
$705K 0.07%
8,000
+5,400
+208% +$473K
2017 Q2
1 quarter
KITE
44
DELISTED
Kite Pharma, Inc.
KITE
$701K 0.07%
+3,900
New +$543K
2017 Q3
0 quarters
ALR
45
DELISTED
Alere Inc
ALR
$637K 0.06%
12,500
+4,440
+55% +$222K
2017 Q2
1 quarter
TRCO
46
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$592K 0.06%
14,500
+6,000
+71% +$244K
2017 Q2
1 quarter
CBF
47
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
$575K 0.06%
+14,000
New +$534K
2017 Q3
0 quarters
CUNB
48
DELISTED
CU Bancorp
CUNB
$504K 0.05%
+13,000
New +$473K
2017 Q3
0 quarters
WSTC
49
DELISTED
West Corporation
WSTC
$493K 0.05%
21,000
+5,400
+35% +$126K
2017 Q2
1 quarter
PCBK
50
DELISTED
Pacific Continental Corp
PCBK
$490K 0.05%
18,200
– –
2017 Q1
2 quarters
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, DLD Asset Management held 140 positions worth $1.02B, up 32% from $768M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

DLD Asset Management withdrew a net $496M in Q3 2017, closing 42 positions and reducing 3 holdings. Its most notable exit was Arista Networks, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, DLD Asset Management opened a new position in PTC Therapeutics worth $12.3M.

  • DLD Asset Management's largest Q3 2017 buy was PTC Therapeutics: 612,543 shares worth $12.3M.
  • DLD Asset Management added most to Insmed in Q3 2017, an estimated $2.74M increase.
  • DLD Asset Management's biggest Q3 2017 reduction was Brocade Communications Systems, Inc. NEW, cutting an estimated $138K.
  • DLD Asset Management fully exited Arista Networks in Q3 2017, selling an estimated $14.9M.
  • DLD Asset Management's ten largest holdings make up 64% of its $1.02B portfolio in Q3 2017.
  • DLD Asset Management opened 46 new positions and closed 42 in Q3 2017.
  • DLD Asset Management's portfolio value rose 32% quarter-over-quarter to $1.02B.

Based on DLD Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.